News archive - ITTBioMed

ITTBioMed: the platform to enhance innovation and technology transfer

September 19, 2023 By Editorial Staff In Biology, Events, Pharmacology, R&D, Regulatory, Safety, Startup, Technologies

The weight of biotech in the pharmaceutical sciences is growing from 20% of the drugs produced in 2012 will constitute 80% in 2030. Italy is among the poles of excellence in Europe but must increase its attractiveness towards venture capital and encourage collaboration between public and private htt...

Pharmacology: Armando Genazzani and Monica DiLuca to Lead the Italian Society of Pharmacology (SIF)

November 18, 2024 By Editorial Staff In Pharmacology

The Italian Society of Pharmacology (SIF) announced, during its 42nd National Congress, the appointments of Armando Genazzani as President and Monica DiLuca as President-Elect for the 2024–2026 term. GENAZZANI, CIRINO, DILUCAThe Italian Society of Pharmacology (SIF) has officially appointed Armand...

Research: Francesco Frati Appointed as New President of Fondazione Toscana Life Sciences

November 08, 2024 By Editorial Staff In R&D

Francesco Frati has been appointed as the new president of the Fondazione Toscana Life Sciences (TLS), following a decision by the TLS Steering Council. Additionally, the Steering Council appointed Andrea Lippo Vanni as the ninth member of the Board of Directors. Francesco Frati as TLS President On ...

Neurorehabilitation: ENEA Tech and Biomedical Foundation Invests in Restorative Neurotechnologies S.r.l. for Digital Therapies

November 08, 2024 By Editorial Staff In Startup

The ENEA Tech and Biomedical Foundation, as the lead investor with an investment of 2 million euros and in collaboration with funds from CDP Venture Capital SGR, Italian Angels for Growth (IAG), and MM Partecipazioni, has completed a 4-million-euro investment round with Restorative Neurotechnologies...

Harnessing Artificial Intelligence to Unlock the Therapeutic Potential of Plant Bioactives

November 08, 2024 By Editorial Staff In Biology, Technologies

A Revolutionary Approach to Biodiversity Conservation, Medicinal Discovery, and Sustainable Botanical Production “We currently know only 0.1% of bioactive compounds in plants, which means a staggering 99.9% remains undiscovered. Expanding our knowledge is challenging, given that a plant genome...

Fighting Glioblastoma: Could CAR-T Cell Therapy Be The Next Frontier?

October 29, 2024 By Editorial Staff In Biology

Glioblastoma multiforme (GBM) is the most common and aggressive form of primary brain tumor, making up over 50% of all gliomas. The incidence of GBM is approximately 3 out of 100,000 people every year and mainly affect people between 45 and 70 years old. GBM is driven by several different mutations ...

CAR-Ts sweep into autoimmunity

October 29, 2024 By Editorial Staff In Biology

The promising results and the safety profile demonstrated in preliminary clinical studies are driving several biotech companies and academic centres to explore CAR-T cells to target autoimmune disorders, rather than just blood cancer. Indeed, in March 2024, the first clinical results demonstrated th...

1 2 3 4 5 6 … 18 19 20 21 22